Innosuisse Startup Roadshow: We stand ready to support you in China

By Simin Yang, Project Coordinator Innovation & Entrepreneurship

It has been six years that swissnex China and Innosuisse launched the Innosuisse China Camp. Throughout this time we have witnessed a tremendous growth in the number of swiss startups keen on exploring the Chinese market potential, and we are delighted to be here in China to support Swiss tech-driven startups in market validation or help them take the deep dive into the local ecosystem.

This March, in collaboration with our colleagues from the US, Brazil, the UK and India, we planned an intensive one-week roadshow with public events and individual meetings to direct engage with our Swiss startups and entrepreneurs. Regrettably, the unexpected outbreak of COVID-19 coronavirus negatively impacted our journey. In the interest of public health and safety, the decision was taken to cancel all public events while still keeping personal meetings with startups, thanks to our Junior Project Manager Niccolò Schlueb who was able to represent swissnex China in Switzerland.

While it was difficult to confirm a large number of meetings due to the COVID-19 situation, we were able to meet and discuss with some particularly ambitious startups including Marc from Juvabis AG, a clinical-stage biopharmaceutical company, a joint spin-off of ETH Zurich and University of Zurich. Juvabis will discuss with their Innosuisse coach about further participation for China after being introduced to the Marktet Validation and Market Entry Camp support offered by swissnex China.

Back in China, due to the circumstances we were prompted to cancel our SwissTech Pavilion at CES ASIA in June and postpone Venture Leaders China to this autumn. Nevertheless, we swiftly initiated a series of webinars and remain supportive online to help swiss startups gain intelligence into the China market. Our upcoming webinar on April 3rd features speakers from the Chinese investment sector to share their insights on Chinese VCs’ appetites and aptitudes regarding foreign startups. 

Although international visits are currently on halt, we remain ever-responsive to all inquiries on fact-finding about the China market. Online applications for market validation and market entry are ongoing as well, as we’re expecting a startups influx and will be ready to carry out our next roadshow in Switzerland in the near-future! It would be a fantastic moment join all our swissnex Network colleagues and provide Swiss startups with a glimpse on Innosuisse Internationalization Camps under the context of different innovation ecosystems.

swissnex Global Innosuisse Internationalization Camps

swissnex Global Innosuisse Internationalization Camps

Innosuisse China Camp Services

Innosuisse China Camp Services

Innosuisse China Camps in Beijing/Shanghai/Guangzhou/Shenzhen/Hong Kong

Innosuisse China Camps in Beijing/Shanghai/Guangzhou/Shenzhen/Hong Kong

Maxwell Biosystems brings MaxTwo World Launch Tour 2019 to China

By Simin Yang, Project Coordinator - Innovation & Entrepreneurship

Maxwell Biosystems is a startup that took part in the Innosuisse Market Entry Camp for China. This time, Maxwell Biosystems arrives in China with its new product MaxTwo. On May 20, swissnex China supported MaxWell Biosystem with the launch of a scientific workshop where we invited local and international speakers from different fields, such as stem cells, organoids, in-vitro technologies, neuroscience/neuro-engineering, toxicity, safety pharmacology, and drug discovery.

图片 1.png

During the workshop, Dr. Urs Frey, CEO of MaxWell Biosystems shared their Company Overview and MEA Technology Trend.

3.png

Dr. Wei Gong, Application Scientist, shared the” iPSCs for CNS Drug Discovery - Phenotype Characterization and Novel Biomarkers”

4.png

The MaxTwo mainframe is an incubator allowing cells to have a proper environment during recording. It is designed for integration with automation systems. Overall, MaxTwo is a powerful electrical imaging system for drug discovery, safety pharmacology, and iPSC phenotyping applications.

 The event allowed the fascinated audience to learn more about the applications of high-resolution microelectrode arrays and to have a hands-on experience with the MaxTwo product.

5.png

 

 Company Overview 

MaxWell Biosystems AG is an electronics and biotechnology company based in Basel, Switzerland that provides instrumentation and solutions to advance neuroscience research and accelerate drug discovery. The company was incorporated in September 2016.

 Product Overview 

MaxWell Biosystems’ MaxTwo is a CMOS-based multiwell HD-MEA platform. It has all the capabilities of MaxOne–it captures high-quality signals at sub cellular resolution from long-term culture experiments. Electrical stimulation protocols can also be performed.

MaxTwo multiwell HD-MEA system allows for easy and vibration-free insertion of the multi-well MEA.